Our results demonstrate that bortezomib and sub-lethal irradiation dramatically enhanced the percentage of SW620 colorectal cancer cells killed by CEA-specific T cells and the combination treatment further increased the percentage of apoptotic cells upon interaction with T cells (Figure 5). The gene discussed is CEACAM5; the disease is colorectal cancer.